NDC 0169-4130

Ozempic

Semaglutide

Ozempic is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Semaglutide.

• Product ID: 0169-4130_16fb5f2c-ad9e-4a1e-9a82-6c888cd7fe13
• NDC: 0169-4130
• Product Type: Human Prescription Drug
• Proprietary Name: Ozempic
• Generic Name: Semaglutide
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2020-09-30
• Marketing Category: NDA / NDA
• Application Number: NDA209637
• Labeler Name: Novo Nordisk
• Substance Name: SEMAGLUTIDE
• Active Ingredient Strength: 1 mg/mL
• Pharm Classes: GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0169-4130-13

1 SYRINGE, PLASTIC in 1 CARTON (0169-4130-13) > 3 mL in 1 SYRINGE, PLASTIC (0169-4130-01)

• Marketing Start Date: 2021-01-03
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Ozempic" or generic name "Semaglutide"

NDC	Brand Name	Generic Name
0169-4130	Ozempic	semaglutide
0169-4132	Ozempic	semaglutide
0169-4136	Ozempic	semaglutide
0169-4181	Ozempic	semaglutide
0169-4772	Ozempic	semaglutide
50090-5138	Ozempic	semaglutide
50090-5139	Ozempic	semaglutide
70518-2143	Ozempic	Ozempic
0169-4501	WEGOVY	semaglutide
0169-4505	WEGOVY	semaglutide
0169-4517	WEGOVY	semaglutide
0169-4524	WEGOVY	semaglutide
0169-4525	WEGOVY	semaglutide